Add like
Add dislike
Add to saved papers

Prediction of early response to uterine artery embolization in fibroids: value of MR signal intensity ratio.

OBJECTIVE: To quantitatively assess magnetic resonance (MR) imaging findings that help predict early post-therapeutic response in fibroids following uterine artery embolization (UAE).

METHODS: Fifteen patients with a total of 52 fibroids underwent UAE. The signal intensity ratio (SIR) on T1-, T2-, diffusion weighted and gadolinium-enhanced images was calculated by dividing the mean signal intensity of fibroids by that of the abdominal rectus muscle. Fibroids were divided into the two groups: affected (post-UAE volume reduction rate>median of all fibroids) and unaffected (<median rate). The SIRs were compared between the two groups. ROC analysis was used to evaluate the predictive performance for differentiating the affected from unaffected lesions.

RESULTS: The SIRs of the affected group were significantly lower on T1-weighted images (0.85±0.1 vs 0.95±0.2) (P=0.0001), but higher on T2-weighted (1.30±0.6 vs 1.12±0.9) (P=0.026) and gadolinium-enhanced images (1.51±0.2 vs 1.20±0.4) (P=0.0002) than those of the unaffected group. There was no significant difference in ADC values between the two groups (P=0.510). The sensitivity, specificity, and area under the ROC curve (AUC) in the prediction of the affected lesions were 92%, 50%, and 0.712 with SIR on T1-weighted images, and 85%, 62%, and 0.731 with SIR on gadolinium-enhanced images, respectively.

CONCLUSIONS: The SIRs on T1-weighted images and gadolinium-enhanced images were useful for the prediction of the changes in size of fibroids responding to UAE.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app